Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021

SELL
$510.68 - $643.45 $2.54 Million - $3.2 Million
-4,969 Closed
0 $0
Q3 2020

Nov 04, 2020

SELL
$454.43 - $535.6 $3.12 Million - $3.68 Million
-6,875 Reduced 58.05%
4,969 $2.56 Million
Q2 2020

Aug 07, 2020

SELL
$334.87 - $493.06 $1.15 Million - $1.7 Million
-3,440 Reduced 22.51%
11,844 $5.35 Million
Q1 2020

May 05, 2020

SELL
$320.01 - $409.07 $364,171 - $465,521
-1,138 Reduced 6.93%
15,284 $5.36 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $61,388 - $71,846
192 Added 1.18%
16,422 $6.08 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $63,955 - $72,500
-210 Reduced 1.28%
16,230 $5.4 Million
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $1.53 Million - $1.67 Million
5,334 Added 48.03%
16,440 $5.14 Million
Q1 2019

Apr 24, 2019

BUY
$224.3 - $317.41 $2.49 Million - $3.53 Million
11,106 New
11,106 $3.4 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $5.83B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Avalon Investment & Advisory Portfolio

Follow Avalon Investment & Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.